They were judged more harshly than someone who didn't lose weight at all
Study participants rated GLP-1 users more negatively than people who didn't lose weight, contradicting expectations that medication-assisted weight loss would reduce stigma. Weight stigma persists regardless of method and intensifies upon weight regain, with cultural narratives framing GLP-1 use as 'taking the easy way out' influencing public judgment.
- One in eight U.S. adults has tried a GLP-1 drug; tens of millions of prescriptions written worldwide
- Study participants rated GLP-1 users more negatively than people who didn't lose weight
- Weight stigma linked to stress, medical care avoidance, and unhealthy coping behaviors
- Rice University study published April 2026 in International Journal of Obesity
Rice University research reveals GLP-1 users face greater social stigma than those who lose weight naturally or maintain their weight, challenging assumptions about weight-loss medication acceptance.
Millions of people have found relief in GLP-1 medications like Ozempic and Wegovy. The drugs work where willpower and diet have failed for decades, transforming weight loss from a grinding, often impossible struggle into something that actually happens. An estimated one in eight American adults has tried one. Celebrities have used them. Executives have used them. The medications have become mainstream enough that tens of millions of prescriptions have been written worldwide in just a few years.
But a new study from Rice University has uncovered something unexpected lurking beneath this success story: the people taking these medications face harsher social judgment than those who lose weight through diet and exercise—and more strikingly, they face harsher judgment than people who don't lose weight at all. The research, led by Erin Standen, an assistant professor of psychological sciences at Rice, was published in the International Journal of Obesity in April 2026. Co-authors included Sean Phelan of the Mayo Clinic and Janet Tomiyama of UCLA.
The study worked by asking participants to evaluate fictional people based on their weight histories. One person had lost weight using a GLP-1 drug. Another had lost weight through diet and exercise. A third had not lost weight. The pattern that emerged was stark. Participants rated those who used GLP-1 medications significantly less favorably than those who achieved weight loss the traditional way. But the most striking finding was this: GLP-1 users were judged more harshly than people who had failed to lose weight entirely. "The GLP-1 users were socially penalized not just compared to someone who lost weight through diet and exercise," Standen said. "They were also rated more negatively than someone who didn't lose weight in the first place." The research suggests that weight-related stigma doesn't vanish when weight does. It shifts. It transforms. It can actually intensify depending on the method used to shed pounds.
Standen noted that a powerful cultural narrative is at work here. There's a widespread belief that using these medications amounts to "taking the easy way out." That belief shapes how people judge those who use them. The stigma operates at multiple points in a person's health journey. Someone might be judged for being overweight. Then, if they choose medication, they're judged for that choice. And if they stop the medication and regain weight—which is common because of cost, insurance restrictions, or side effects—they face judgment again. The researchers found that weight regain triggered harsh evaluation regardless of whether it followed GLP-1 use or traditional dieting. The stigma, it seems, attaches itself to the outcome rather than the method.
The implications extend beyond hurt feelings or social awkwardness. Standen emphasized that weight stigma has documented health consequences. People who feel judged for their health choices are less likely to seek medical care. They experience elevated stress. They're more prone to unhealthy coping behaviors. They're less likely to talk openly with their doctors. As GLP-1 medications continue their rapid expansion into mainstream medicine, these attitudes could undermine the very health benefits the drugs are designed to provide. Someone might avoid using a medication that could help them because they fear social judgment. Or they might stop using it prematurely for the same reason. The stigma becomes a barrier to care.
Standen's work is part of a broader effort to understand how people can make health decisions without feeling condemned for those choices. She spoke about the power of cultural scripts—the deeply embedded stories we tell ourselves about what a healthy body should look like and how someone should achieve it. Those stories can override what's actually medically sound. "There's such a strong cultural script around weight and what a 'healthy' body should look like," she said. "And those messages can get in the way of people doing what's actually best for them." Her hope is that these findings will help shift public attitudes, creating space for people to make informed decisions about their health without fear of judgment. As these medications become more common, that cultural shift may become essential to ensuring they actually deliver the health benefits they promise.
Citações Notáveis
The GLP-1 users were socially penalized not just compared to someone who lost weight through diet and exercise. They were also rated more negatively than someone who didn't lose weight in the first place.— Erin Standen, Rice University
There's a narrative that using these medications is 'taking the easy way out,' and that belief seems to shape how people are judged.— Erin Standen, Rice University
A Conversa do Hearth Outra perspectiva sobre a história
So the study found that people judge GLP-1 users more harshly than people who don't lose weight at all. That seems backwards. Shouldn't weight loss be celebrated?
You'd think so. But the judgment isn't really about the outcome. It's about the perceived shortcut. There's this deep cultural belief that weight loss only counts if it comes from discipline and suffering—diet and exercise. Medication feels like cheating.
But these are prescription drugs. They're medical treatments. Why would people see them differently than, say, insulin for diabetes?
That's the key question. Weight has always been treated differently in our culture. It's been moralized. People see it as a character issue rather than a medical one. So when you use a drug to address it, you're not just treating a condition—you're violating an unspoken rule about how you're supposed to earn your health.
What happens to someone who feels this judgment? Does it actually change their behavior?
Yes. Stigma creates stress, which can lead people to avoid medical care entirely. Someone might not fill a prescription because they're afraid of how others will perceive them. Or they might stop taking a medication that's working because the social cost feels too high. The irony is that the judgment itself becomes a barrier to health.
The study also looked at weight regain. That seems like it would be judged harshly no matter what.
Exactly. Whether you regained weight after GLP-1 or after dieting, people judged you more harshly than someone who lost weight and kept it off. But here's the thing—with GLP-1, regain is often inevitable when you stop the medication. It's not a failure of willpower. It's how the drug works. Yet the cultural narrative doesn't account for that.
So what changes this? How do we shift the narrative?
That's what Standen is asking. She's saying we need to stop moralizing health choices. A medication is a tool. Using it isn't weakness or laziness. It's medicine. Until we separate weight loss from character judgment, people will keep facing this impossible choice between their health and their dignity.